Medzip Pharmaceuticals Private Limited

Medzip Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24301KA2013PTC072177 Incorporated 28 November 2013 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹23.8 Lakh
▼ 14% YoY
Net profit · FY 2025
₹1.14 Lakh
Net margin 4.8%
EBITDA · FY 2025
₹1.39 Lakh
EBITDA margin 5.8%
Authorised capital
₹1.5 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
4
As per MCA filings

About Medzip Pharmaceuticals Private Limited

Data last updated:

Medzip Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24301KA2013PTC072177. Its GSTIN is 29AAICM9822B1ZC (Karnataka).

The company has an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Anand Pandurang Kulkarni and Santosh Baburao Bommannavar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 8th F Cross Vidyamanyanagara Andra Halli Main Road, Bangalore, Karnataka, India – 560091.

As per the financials filed for FY 2025, the company reported a revenue of ₹23.8 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.14 Lakh (net margin 4.8%) and EBITDA of ₹1.39 Lakh (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 8% over five years.

As per MCA filings, the company has open charges of ₹5 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24301KA2013PTC072177
Registration Number 072177
Incorporation Date 28 November 2013
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Medzip Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    12 8th F Cross Vidyamanyanagara Andra Halli Main Road, Bangalore, Karnataka, India – 560091
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Medzip Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Medzip Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medzip Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Medzip Pharmaceuticals Private Limited, buy the company report.

Financials of Medzip Pharmaceuticals Private Limited

FY 2025 filings available

Medzip Pharmaceuticals Private Limited reported revenue of ₹23.8 Lakh (down 14% YoY) for FY 2025.

Revenue · FY 2025
₹23.8 Lakh ▼ 14%
Net profit · FY 2025
₹1.14 Lakh margin 4.8%
EBITDA · FY 2025
₹1.39 Lakh margin 5.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▼ 3%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 70%
5 years · compounded
▼ 10%

Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 14% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.8%
Net Profit Margin4.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medzip Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medzip Pharmaceuticals Private Limited

Medzip Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anand Pandurang KulkarniDirector28 Nov 201312 Years 10 MonthsCurrent
Santosh Baburao BommannavarDirector28 Nov 201312 Years 10 MonthsCurrent
Kalpana Anilkumar PacheriDirector21 Jan 201412 Years 9 MonthsCurrent
Purnapradna Ranjan KulkarniDirector28 Nov 201312 Years 10 MonthsCurrent

Auditor

Medzip Pharmaceuticals Private Limited is audited by KIRAN HIREMATH & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
KIRAN HIREMATH & COFY 2022016311S

Shareholding

The shareholding of Medzip Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Medzip Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Mar 2016100016660Others₹5 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medzip Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medzip Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAICM9822B1ZCKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Medzip Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medzip Pharmaceuticals Private Limited has 4 board changes on record since 2013: 4 appointments. The latest: Kalpana Anilkumar Pacheri was appointed as Director on 21 Jan 2014.

AGM
Medzip Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medzip Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Others amounted to Rs. 5.00 Lakh with Charge ID 100016660 was registered on 10 Mar 2016.
Appointed
Kalpana Anilkumar Pacheri was appointed as Director.
Appointed
Anand Pandurang Kulkarni was appointed as Director.
Appointed
Purnapradna Ranjan Kulkarni was appointed as Director.
Appointed
Santosh Baburao Bommannavar was appointed as Director.
Incorporation
28 Nov 2013
Medzip Pharmaceuticals Private Limited was registered on 28 Nov 2013 with Roc Bangalore & aged 12 years 10 months as per MCA records.

Frequently asked questions

Medzip Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2013 (13+ years old) and is registered under CIN U24301KA2013PTC072177.

Medzip Pharmaceuticals has 4 current directors:

The latest financial statements of Medzip Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Medzip Pharmaceuticals is 29AAICM9822B1ZC, registered in Karnataka.

The CIN (Corporate Identification Number) of Medzip Pharmaceuticals is U24301KA2013PTC072177. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medzip Pharmaceuticals was incorporated on 28 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.

Kalpana Anilkumar Pacheri was appointed as Director on 21 Jan 2014. Anand Pandurang Kulkarni was appointed as Director on 28 Nov 2013. Purnapradna Ranjan Kulkarni was appointed as Director on 28 Nov 2013. Medzip Pharmaceuticals has 4 board changes on record in total.

The registered office of Medzip Pharmaceuticals is at 12 8th F Cross Vidyamanyanagara Andra Halli Main Road, Bangalore, Karnataka, India – 560091.

Medzip Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Medzip Pharmaceuticals has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.